Clinical Evidence · India

Vision Therapy Success Rate in India — What the Evidence Actually Shows

How effective is vision therapy? The answer depends on the condition being treated. For convergence insufficiency, the CITT randomised controlled trial found 73% success with in-office therapy. Here is the full picture — condition by condition, evidence by evidence.

Book a Vision Assessment WhatsApp Us

73%

CI success rate — CITT trial

Up to 95%

amblyopia improvement in children

80–90%

accommodative esotropia resolution

50–70%

exotropia control without surgery

Why "Does Vision Therapy Work?" Needs a More Specific Answer

Vision therapy is not a single treatment — it is a family of clinical interventions used for different visual system conditions. Asking "what is the success rate of vision therapy?" without specifying the condition is like asking "what is the success rate of surgery?" — the answer depends entirely on what is being treated, at what stage, by whom, and using what methods.

For some conditions — particularly convergence insufficiency — the evidence base is exceptionally strong, with multiple randomised controlled trials demonstrating outcomes superior to any other intervention. For others, the evidence is from prospective cohort studies and clinical consensus. For a small number of conditions, vision therapy is part of a multidisciplinary management plan rather than the primary treatment.

The following section breaks down vision therapy success rates condition by condition, citing the specific evidence where it exists. These are the real numbers — not marketing claims. Where success rates are modest, we say so. Where they are high, we explain why. This is the information you need to make an informed decision about whether vision therapy at our Chennai or Hyderabad clinic is the right choice for your condition.

Vision Therapy Success Rates by Condition

Each condition has different clinical evidence, different outcome metrics, and different factors that affect results. Here is an honest, evidence-based summary.

73%

SUCCESS RATE

Convergence Insufficiency

The CITT (Convergence Insufficiency Treatment Trial), a multi-site, randomised controlled trial funded by the National Eye Institute (USA), compared in-office vision therapy against home pencil push-up exercises and home computer therapy. In-office vergence therapy achieved a 73% success rate (defined as normalised or improved NPC, symptom scores, and stereoacuity) versus 33% for home exercises alone. This is the gold standard evidence for any vision therapy condition.

Evidence level: Level 1 — Multiple randomised controlled trials (CITT 2008, CITT-ART 2019) · Applicable to India: Yes — convergence insufficiency is one of the most common functional vision diagnoses at our Chennai clinic.

Up to 95%

IN CHILDREN

Amblyopia (Lazy Eye)

Amblyopia treatment success rates depend heavily on age and compliance. In children under 7, appropriately treated amblyopia achieves meaningful visual acuity improvement in 80-95% of cases. The PEDIG (Pediatric Eye Disease Investigator Group) trials demonstrated that patching combined with atropine or active vision therapy produces significantly better outcomes than patching alone. Dichoptic therapy (binocular amblyopia treatment) is showing success rates of 60-75% in children 4-10 years, with an emerging evidence base for adults.

Evidence level: Level 1 for patching + therapy in children · Level 2 for adult amblyopia and dichoptic approaches · Note: Success rates drop significantly after age 12 without specialist intervention.

80–90%

RESOLUTION RATE

Accommodative Esotropia

Full accommodative esotropia (the inward turn is entirely caused by excessive focusing effort in an uncorrected longsighted eye) has one of the highest success rates in paediatric eye care: 80-90% of patients achieve complete resolution of the squint with the correct spectacle prescription alone. Residual non-accommodative esotropia following full optical correction responds well to vision therapy in a further significant proportion of patients. Surgery is avoided in the large majority of accommodative esotropia cases when properly managed with glasses and therapy.

Evidence level: Level 1-2 for optical correction · Level 2-3 for vision therapy component · Applicable to India: Strongly yes — accommodative esotropia is very commonly seen at our Chennai and Hyderabad clinics.

50–70%

CONTROL RATE

Intermittent Exotropia

Success rates for non-surgical treatment of intermittent exotropia range from 50-70% for achieving "good control" (defined as the Newcastle Control Scale score of ≤3). The evidence base for vision therapy in intermittent exotropia is Level 2-3, with prospective studies and clinical consensus supporting non-surgical management as the appropriate first-line approach. Vision therapy is recommended before surgery is considered, as surgery for intermittent exotropia carries a significant recurrence rate (20-40% within 5 years) when not combined with post-operative vision therapy.

Evidence level: Level 2-3 · Note: Outcomes are significantly better when therapy begins before the deviation becomes constant.

Functional
Improvement

NEURO-REHAB

Post-Concussion & Post-Stroke Neuro-Optometric Rehabilitation

Neuro-optometric rehabilitation following TBI, concussion, and stroke targets specific deficits — binocular dysfunction, oculomotor impairment, visual field deficits, and spatial disorientation. Success is measured in terms of functional improvement (reading recovery, mobility, independence) rather than a single percentage. Published studies report significant reductions in PCSS symptom burden, improved oculomotor scores, and functional reading recovery in 60-80% of appropriately selected patients following structured neuro-optometric rehabilitation. Prism therapy for visual midline shift achieves measurable improvements in balance and spatial orientation.

Evidence level: Level 2-3, multiple clinical trials · India note: Significantly underutilised — most post-stroke patients in India receive no vision rehabilitation at all.

Vision Therapy Success in India — What Is Different

The clinical trials cited above were conducted primarily in the United States and Europe. However, the underlying neuroscience — how vergence training works, how suppression is reduced, how neural plasticity enables binocular system change — is universal. Vision therapy success rates at specialist COVD-affiliated clinics in India, including Caring Vision Therapy, are consistent with the international published evidence for patients who complete the full programme.

The main factor that affects outcomes in India is not the therapy itself but the delay before starting. Most patients arrive having spent months or years receiving diagnoses that missed the underlying functional vision problem. Children with convergence insufficiency have already fallen behind at school. Adults with post-concussion visual symptoms have been told their eyes are normal. The later therapy begins, the more ground must be recovered — and for some conditions (notably amblyopia), earlier treatment genuinely produces better outcomes.

What determines outcome at Caring Vision Therapy: Condition type and severity · age at presentation · compliance with home programme component · whether co-occurring conditions (amblyopia, refractive error) are also managed · number of therapy sessions completed. We track all of these with objective clinical metrics at every session and provide transparent outcome data throughout your programme.

If you are uncertain whether vision therapy is likely to be effective for your or your child's specific condition, the right first step is a comprehensive functional vision evaluation at our Chennai or Hyderabad clinic. After evaluation, our COVD-certified specialists will give you an honest assessment of what improvement is realistic, what the evidence says, and what the programme will involve.

How We Measure Vision Therapy Outcomes at CVT

Progress in vision therapy must be objective, not just subjective. These are the clinical tools we use at Caring Vision Therapy, Chennai to measure whether therapy is working.

Near Point of Convergence

Measured at every session for convergence insufficiency cases. Normal NPC is under 6 cm. We track break and recovery points to verify binocular function improvement over time.

CISS Symptom Survey

The validated Convergence Insufficiency Symptom Survey scores 15 visual symptoms from 0 to 60. We baseline at evaluation and re-score every 6 sessions to quantify symptom reduction objectively.

Stereoacuity Testing

Stereoacuity (3D depth perception) is a direct measure of binocular fusion quality. We use Randot Stereotest and Frisby stereotest to track improvement from baseline to discharge.

Newcastle Control Scale

Used specifically for intermittent exotropia to score how well the child controls the outward deviation in home, clinic, and testing conditions. Lower scores = better control.

Vergence Ranges

Positive and negative fusional vergence ranges measure the binocular system's full range of comfortable movement. We track these against Morgan's norms to verify programme completion criteria are met.

Visual Acuity Progress

For amblyopia cases, ETDRS-equivalent visual acuity is measured at every session. We track improvement in lines of acuity and compare against PEDIG trial benchmarks for age-matched patients.

Common Questions About Vision Therapy Success

What is the success rate of vision therapy in India?

It depends on the condition. Convergence insufficiency: 73% (CITT trial). Accommodative esotropia: 80-90% resolution with glasses + therapy. Amblyopia in children under 10: up to 95% improvement. Intermittent exotropia: 50-70% good control without surgery. These rates apply to full programmes delivered by specialist COVD-certified clinicians — not home exercises or apps.

Does vision therapy work for adults in India?

Yes. Convergence insufficiency, binocular vision dysfunction, and post-concussion visual symptoms are highly treatable in adults. Amblyopia in adults has lower success rates than in children, but meaningful improvement is achievable in patients up to their 40s, especially with binocular dichoptic approaches. Neuroplasticity persists well into adulthood for visually-directed functions.

How long until I see results from vision therapy?

Most patients notice symptomatic improvement within 6-12 weeks of structured in-office therapy. Full clinical outcomes (normal vergence ranges, symptom resolution, stereoacuity targets) typically require 12-36 weeks depending on the condition. Progress is measured objectively at every session so improvement is visible in the data, not just the symptoms.

Can vision therapy fail? What happens if it doesn't work?

Yes, vision therapy does not achieve full outcomes in every case. Factors that reduce success include very large-angle constant strabismus (where surgery is needed first), amblyopia presenting after the sensitive period, poor home programme compliance, and co-occurring conditions that are not addressed simultaneously. If clinical outcomes are not progressing as expected, we reassess the treatment plan and discuss alternative or additional interventions, including surgical referral where appropriate.

Is vision therapy at CVT Chennai evidence-based?

Yes. Our therapists are COVD-certified (College of Optometrists in Vision Development), the internationally recognised certification for vision therapy specialists. We use only evidence-based protocols for each condition and track outcomes against published clinical benchmarks. Treatment protocols are regularly reviewed against current peer-reviewed literature. We do not offer interventions without a clinical evidence base.

Find Out If Vision Therapy Is Right for Your Condition

The first step is a comprehensive functional vision evaluation at our Chennai or Hyderabad clinic. After evaluation, you'll receive an honest clinical assessment of likely outcomes — not a sales pitch.

Book Evaluation in Chennai or Hyderabad Vision Therapy Cost Guide